Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | MNPR-101-PCTA-177Lu |
| Synonyms | |
| Therapy Description |
Limited information is currently available on MNPR-101-PCTA-177Lu, a putative radiotherapy targeting PLAUR (uPAR) (Sep 2024). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| MNPR-101-PCTA-177Lu | Limited information is currently available on MNPR-101-PCTA-177Lu, a putative radiotherapy targeting PLAUR (uPAR) (Sep 2024). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06980519 | Expanded access | MNPR-101-PCTA-177Lu | MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer | Available | USA | 0 |
| NCT06617169 | Phase I | MNPR-101-PCTA-177Lu | Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors | Recruiting | AUS | 0 |